Clinical Trial

Thoraflex Hybrid Post-Market Study

Study Description

Thoraflex Hybrid Post-Market Study

This is a global, prospective non-interventional, multi-centre, post-market study of the Vascutek Thoraflexa"c Hybrid system in patients with acute thoracic aortic syndrome, subacute/chronic dissection of the aorta and aortic aneurysm.


Locations Selected Location


No pharmaceutical medication involved No pharmaceutical medication involved
Recruiting patients only Recruiting patients only

Behavioral - EQ-5D-5L QOL questionnaire

Written questionnaire

Additional Information

Official Study Title

Thoraflex Hybrid Post-Market Study

Clinical Trial ID


ParticipAid ID